Effect of titanium dioxide nanoparticles on histone modifications and histone modifying enzymes expression in human cell lines

References

• Abi Kahalil, C. 2014. “The Emerging Role of Epigenetic in Cardiovascular Disease.” Therapeutic Advances in Chronic Disease 5: 178–187.
   PubMedGoogle Scholar
• Allis, C. D., S. L. Berger, J. Cote, S. Dent, T. Jenuwien, T. Kouzarides, L. Pillus, et al. 2007. “New Nomenclature for Chromatin-Modifying Enzymes.” Cell 131 (4): 633–636. doi:10.1016/j.cell.2007.10.039.
   PubMed Web of Science ®Google Scholar
• Arita, A., and M. Costa. 2014. “Oxidative Stress and the Epigenome in Human Disease.” Journal of Genetics Genome Research 1 (2): 1–5.
   Google Scholar
• Baccarelli, A., and V. Bollati. 2009. “Epigenetics and Environmental Chemicals.” Current Opinion in Pediatrics 21 (2): 243–251. doi:10.1097/mop.0b013e32832925cc.
   PubMed Web of Science ®Google Scholar
• Bai, X. L., L. H. Wu, T. B. Liang, Z. Q. Liu, J. J. Li, D. L. Li, H. Y. Xie, et al. 2007. “Overexpression of Myocyte Enhancer Factor 2 and Histone Hyperacetylation in Hepatocellular Carcinoma.” Journal of Cancer Research and Clinical Oncology 134 (1): 83–91. doi:10.1007/s00432-007-0252-7.
   PubMed Web of Science ®Google Scholar
• Barber, M. F., E. Michishita-Kioi, Y. Xi, L. Tasselli, M. Kioi, Z. Moqtaderi, R. I. Tennen, et al. 2012. “SIRT7 Links H3K18 Deacetylation to Maintenance of Oncogenic Transformation.” Nature 487 (7405): 114–118. doi:10.1038/nature11043.
   PubMed Web of Science ®Google Scholar
• Barlési, F., G. Giaccone, M. I. Gallegos-Ruiz, A. Loundou, S. W. Span, P. Lefesvre, F. A. E. Kruyt, et al. 2007. “Global Histone Modifications Predict Prognosis of Resected Non-Small Cell Lung Cancer.” Journal of Clinical Oncology 25 (28): 4358–4364. doi:10.1200/JCO.2007.11.2599.
   PubMed Web of Science ®Google Scholar
• Baylin, S. B., and P. A. Jones. 2011. “A Decade of Exploring the Cancer Epigenome - Biological and Translational Implications.” Nature Reviews. Cancer 11 (10): 726–734. doi:10.1038/nrc3130.
   PubMed Web of Science ®Google Scholar
• Benard, A., I. J. Goossens-Beumer, A. Q. van Hoesel, W. de Graaf, H. Horati, H. Putter, Z. EDM, C. J. H. van de Velde, and P. J. K. Kuppen. 2014. “Histone Trimethylation at H3K4, H3K9, and H4K20 Correlated with Patient Survival and Tumor Recurrence in Early-Stage Colon Cancer.” BMC Cancer 14 (1): 531–531? doi:10.1186/1471-2407-14-531.
   PubMedGoogle Scholar
• Bhat, A. V., S. Hora, A. Pal, S. Jha, and R. Taneja. 2018. “Stressing the (Epi)Genome: Dealing with Reactive Oxygen Species in Cancer.” Antioxidants & Redox Signaling 29 (13): 1273–1294. doi:10.1089/ars.2017.7158.
   PubMed Web of Science ®Google Scholar
• Cai, M.-Y., J.-H. Hou, H.-L. Rao, R.-Z. Luo, M. Li, X.-Q. Pei, M. C. Lin, et al. 2011b. “High Expression of H3K27me3 in Human Hepatocellular Carcinoma Correlates Closely with Vascular Invasion and Predicts Worse Prognosis in Patients.” Molecular Medicine 17 (1-2): 12–20. doi:10.2119/molmed.2010.00103.
   PubMed Web of Science ®Google Scholar
• Cai, M.-Y., Z.-T. Tong, W. Zhu, Z.-Z. Wen, H.-L. Rao, L.-L. Kong, X.-Y. Guan, et al. 2011a. “H3K27me3 Protein is a Promising Predictive Biomarker of Patients’ Survival and Chemoradioresistance in Human Nasopharyngeal Carcinoma.” Molecular Medicine 17 (11-12): 1137–1145. doi:10.2119/molmed.2011.00054.
   PubMed Web of Science ®Google Scholar
• Carvalho, S., M. Freitas, L. Antunes, S. Monteiro-Reis, M. Vieira-Coimbra, A. Tavares, S. Paulino, J. F. Videira, C. Jerónimo, and R. Henrique. 2018. “Prognostic Value of Histone Marks H3K27me3 and H3K9me3 and Modifying Enzymes EZH2, SETDB1 and LSD-1 in Colorectal Cancer.” Journal of Cancer Research and Clinical Oncology 144 (11): 2127–2137. doi:10.1007/s00432-018-2733-2.
   PubMed Web of Science ®Google Scholar
• Casciello, F., K. Windloch, F. Gannon, and J. S. Lee. 2015. “Functional Role of G9a Histone Methyltransferase in Cancer.” Frontiers in Immunology 6: 487. doi:10.3389/fimmu.2015.00487.
   PubMed Web of Science ®Google Scholar
• Chen, H. W., S. F. Su, C. T. Chien, W. H. Lin, S. L. Yu, C. C. Chou, J. J. Chen, and P. C. Yang. 2006. “Titanium Dioxide Nanoparticles Induce Emphysema-like Lung Injury in Mice.” FASEB Journal 20 (13): 2393–2395. doi:10.1096/fj.06-6485fje.
   PubMed Web of Science ®Google Scholar
• Chervona, Y., and M. Costa. 2012. “Histone Modifications and Cancer: biomarkers of Prognosis?” American Journal of Cancer Research 2: 589–597.
   PubMed Web of Science ®Google Scholar
• Cheung, N., L. C. Chan, A. Thompson, M. I. Cleary, and C. W. E. So. 2007. “Protein Arginine-Methyltransferase-Dependent Oncogenesis.” Nature Cell Biology 9 (10): 1208–1215. doi:10.1038/ncb1642.
   PubMed Web of Science ®Google Scholar
• Colamaio, M., F. Puca, E. Ragozzino, M. Gemei, M. Decaussin-Petrucci, C. Aiello, A. U. Bastos, et al. 2015. “miR-142-3p down-Regulation Contributes to Thyroid Follicular Tumorigenesis by Targeting ASH1L and MLL1.” The Journal of Clinical Endocrinology and Metabolism 100 (1): E59–E69. doi:10.1210/jc.2014-2280.
   PubMed Web of Science ®Google Scholar
• Damodaran, S., N. Damaschke, J. Gawdzik, B. Yang, C. Shi, G. O. Allen, W. Huang, J. Denu, and D. Jarrard. 2017. “Dysregulation of Sirtuin 2 (SIRT2) and Histone H3K18 Acetylation Pathways Associates with Adverse Prostate Cancer Outcomes.” BMC Cancer 17 (1): 874. doi:10.1186/s12885-017-3853-9.
   PubMedGoogle Scholar
• Duan, Y., J. Liu, L. Ma, N. Li, H. Liu, J. Wang, L. Zheng, et al. 2010. “Toxicological Characteristics of Nanoparticulate Anatase Titanium Dioxide in Mice.” Biomaterials 31 (5): 894–899. doi:10.1016/j.biomaterials.2009.10.003.
   PubMed Web of Science ®Google Scholar
• Falandry, C., G. Fourel, V. Galy, T. Ristriani, B. Horard, E. Bensimon, G. Salles, E. Gilson, and F. Magdinier. 2010. “CLLD8/KMT1F is a Lysine Methyltransferase That is Important for Chromosome Segregation.” The Journal of Biological Chemistry 285 (26): 20234–20241. doi:10.1074/jbc.M109.052399.
   PubMed Web of Science ®Google Scholar
• Feil, R., and M. F. Fraga. 2012. “Epigenetics and the Environment: Emerging Patterns and Implications.” Nature Reviews. Genetics 13 (2): 97–109. doi:10.1038/nrg3142.
   PubMed Web of Science ®Google Scholar
• Feng, B., M. A. Ruiz, and S. Chakrabarti. 2013. “Oxidative-Stress-Induced Epigenetic Changes in Chronic Diabetic Complications.” Canadian Journal of Physiology and Pharmacology 91 (3): 213–220. doi:10.1139/cjpp-2012-0251.
   PubMed Web of Science ®Google Scholar
• Ferrari, L., S. Pavanello, and V. Bollati. 2019. “Molecular and Epigenetic Markers as Promising Tools to Quantify the Effect of Occupational Exposures and the Risk of Developing Non-Communicable Diseases.” La Medicina del Lavoro 110 (3): 168–190.
   PubMed Web of Science ®Google Scholar
• Francis, N. J., R. E. Kingston, and C. L. Woodcock. 2004. “Chromatin Compaction by a Polycomb Group Protein Complex.” Science 306 (5701): 1574–1577. doi:10.1126/science.1100576.
   PubMed Web of Science ®Google Scholar
• Gao, F., N. Ma, H. Zhou, Q. Wang, H. Zhang, P. Wang, H. Hou, H. Wen, and L. Li. 2016. “Zinc Oxide Nanoparticles-Induced Epigenetic Change and G2/M Arrest Are Associated with Apoptosis in Human Epidermal Keratinocytes.” International Journal of Nanomedicine 11: 3859–3874. doi:10.2147/IJN.S107021.
   PubMed Web of Science ®Google Scholar
• Ge, J., W. Yu, J. Li, H. Ma, P. Wang, Y. Zhou, Y. Wang, J. Zhang, and G. Shi. 2021. “USP16 Regulates Castration-Resistant Prostate Cancer Cell Proliferation by Deubiquitinating and Stabilizing c-MYC.” Journal of Experimental and Clinical Cancer Research 40 (59): 1–15.
   PubMedGoogle Scholar
• He, L.-R., M.-Z. Liu, B.-K. Li, H.-L. Rao, Y.-J. Liao, X.-Y. Guan, Y.-X. Zeng, and D. Xie. 2009. “Prognostic Impact of H3K27me3 Expression on Locoregional Progression After Chemoradiotherapy in Esophageal Squamous Cell Carcinoma.” BMC Cancer 9: 461. doi:10.1186/1471-2407-9-461.
   PubMed Web of Science ®Google Scholar
• Ho, T. H., P. Kapur, R. W. Joseph, D. J. Serie, J. E. Eckel-Passow, P. Tong, J. Wang, et al. 2016. “Loss of Histone H3 Lysine 36 Trimethylation is Associated with an Increased Risk of Renal Cell Carcinoma-Specific Death.” Modern Pathology 29 (1): 34–42. doi:10.1038/modpathol.2015.123.
   PubMed Web of Science ®Google Scholar
• Hou, J., L. Wang, C. Wang, S. Zhang, H. Liu, S. Li, and X. Wang. 2019. “Toxicity and Mechanisms of Action of Titanium Dioxide Nanoparticles in Living Organisms.” Journal of Environmental Sciences (China) 75: 40–53. doi:10.1016/j.jes.2018.06.010.
   PubMedGoogle Scholar
• Huang, W.-L., C.-W. Luo, C.-L. Chou, C.-C. Yang, T.-J. Chen, C.-F. Li, and Pan, M.-R. 2020. “High Expression of UBE2B as a Poor Prognosis Factor in Patients with Rectal Cancer following Chemoradiotherapy.” Anticancer Research 40 (11): 6305–6317. doi:10.21873/anticanres.14651.
   PubMed Web of Science ®Google Scholar
• Hwang, J. Y., K. A. Aromolaran, and R. S. Zukin. 2017. “The Emerging Field of Epigenetics in Neurodegeneration and Neuroprotection.” Nature Reviews. Neuroscience 18 (6): 347–361. doi:10.1038/nrn.2017.46.
   PubMed Web of Science ®Google Scholar
• IARC. 2010. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Carbon Black, Titanium Dioxide, and Talc. Lyon: International Agency for Research on Cancer
   Google Scholar
• Iavicoli, I., V. Leso, L. Fontana, and A. Bergamaschi. 2011. “Toxicological Effects of Titanium Dioxide Nanoparticles: A Review of in Vitro Mammalian Studies.” European Review for Medical and Pharmacological Sciences 15 (5): 481–508.
   PubMed Web of Science ®Google Scholar
• Jakovcevski, M., and S. Akbarian. 2012. “Epigenetic Mechanisms in Neurological Disease.” Nature Medicine 18 (8): 1194–1202. doi:10.1038/nm.2828.
   PubMed Web of Science ®Google Scholar
• Jayaram, D. T., A. Kumar, L. E. Kippner, P.-Y. Ho, M. L. Kemp, Y. Fan, and C. K. Payne. 2019. “TiO2 Nanoparticles Generate Superoxide and Alter Gene Expression in Human Lung Cells.” RSC Advances 9 (43): 25039–25047. doi:10.1039/c9ra04037d.
   PubMed Web of Science ®Google Scholar
• Juliano, C. N., P. Izetti, M. P. Pereira, A. P. dos Santos, C. P. Bravosi, A. L. Abujamra, P. A. Prolla, A. B. Osvaldt, and M. I. A. Edelweiss. 2016. “H4K12 and H3K18 Acetylation Associates with Poor Prognosis in Pancreatic Cancer.” Applied Immunohistochemistry & Molecular Morphology 24 (5): 337–344. doi:10.1097/PAI.0000000000000194.
   Web of Science ®Google Scholar
• Kang, K. A., R. Zhang, G. Y. Kim, S. C. Bae, and J. W. Hyun. 2012. “Epigenetic Changes Induced by Oxidative Stress in Colorectal Cancer Cells: methylation of Tumor Suppressor RUNX3.” Tumour Biology 33 (2): 403–412. doi:10.1007/s13277-012-0322-6.
   PubMedGoogle Scholar
• Karmodiya, K., A. R. Krebs, M. Oulad-Abdelghani, H. Kimura, and L. Tora. 2012. “H3K9 and H3K14 Acetylation co-Occur at Many Gene Regulatory Elements, While H3K14ac Marks a Subset of Inactive Inducible Promoters in Mouse Embryonic Stem Cells.” BMC Genomics 13: 424–424? doi:10.1186/1471-2164-13-424.
   PubMed Web of Science ®Google Scholar
• Khan, I., K. Saeed, and I. Khan. 2019. “Nanoparticles: Properties, Applications and Toxicities.” Arabian Journal of Chemistry 12 (7): 908–931. doi:10.1016/j.arabjc.2017.05.011.
   Web of Science ®Google Scholar
• Kietzman, T., A. Petry, A. Shvetsova, J. M. Gerhold, and A. Gorlach. 2017. “The Epigenetic Landscape Related to Reactive Oxygen Species Formation in the Cardiovascular System.” British Journal of Pharmacology 174 (12): 1533–1554. doi:10.1111/bph.13792.
   PubMed Web of Science ®Google Scholar
• Kim, Y.-R., B. K. Lee, R.-Y. Park, N. T. X. Nguyen, J. A. Bae, D. D. Kwon, and C. Jung. 2010. “Differential CARM1 Expression in Prostate and Colorectal Cancers.” BMC Cancer 10 (1): 197. doi:10.1186/1471-2407-10-197.
   PubMed Web of Science ®Google Scholar
• Kouzarides, T. 2007. “Chromatin Modifications and Their Function.” Cell 128 (4): 693–705. doi:10.1016/j.cell.2007.02.005.
   PubMed Web of Science ®Google Scholar
• Kreuz, S., and W. Fischle. 2016. “Oxidative Stress Signaling to Chromatin in Health and Disease.” Epigenomics 8 (6): 843–862. doi:10.2217/epi-2016-0002.
   PubMed Web of Science ®Google Scholar
• Kurdistani, S. K. 2011. “Histone Modifications in Cancer Biology and Prognosis.” Progress in Drug Research 67: 91–106.
   PubMedGoogle Scholar
• Langevin, S. M., R. A. Kratzke, and K. T. Kelsey. 2015. “Epigenetics of Lung Cancer.” Translational Research : The Journal of Laboratory and Clinical Medicine 165 (1): 74–90. doi:10.1016/j.trsl.2014.03.001.
   PubMed Web of Science ®Google Scholar
• Leshner, M., S. Wang, C. Lewis, H. Zheng, X. A. Chen, L. Santy, and Y. Wang. 2012. “PAD4 Mediated Histone Hypercitrullination Induces Heterochromatin Decondensation and Chromatin Unfolding to Form Neutrophil Extracellular Trap-like Structures.” Frontiers in Immunology 3: 307. doi:10.3389/fimmu.2012.00307.
   PubMed Web of Science ®Google Scholar
• Li, S., L. Shen, and K.-N. Chen. 2018. “Association between H3K4 Methylation and Cancer Prognosis: A Meta-Analysis.” Thoracic Cancer 9 (7): 794–799. doi:10.1111/1759-7714.12647.
   PubMed Web of Science ®Google Scholar
• Li, Q.-L., D.-Y. Wang, L.-G. Ju, J. Yao, C. Gao, P.-J. Lei, L.-Y. Li, X.-L. Zhao, and M. Wu. 2019. “The Hyper-Activation of Transcriptional Enhancers in Breast Cancer.” Clinical Epigenetics 11 (1): 48. doi:10.1186/s13148-019-0645-x.
   PubMedGoogle Scholar
• Lien, H.-C., Y.-M. Jeng, Y-l. Jhuang, and R.-H. Yuan. 2018. “Increased Trimethylation of Histone H3K36 Associated with Biliary Differentiation and Predicts Poor Prognosis in Resectable Hepatocellular Carcinoma.” PLoS One 13 (10): e0206261–15. doi:10.1371/journal.pone.0206261.
   PubMed Web of Science ®Google Scholar
• Liu, B.-L., J.-X. Cheng, X. Zhang, R. Wang, W. Zhang, H. Lin, X. Xiao, S. Cai, X.-Y. Chen, and H. Cheng. 2010. “Global Histone Modification Patterns as Prognostic Markers to Classify Glioma Patients.” Cancer Epidemiology Biomarkers & Prevention 19 (11): 2888–2896. doi:10.1158/1055-9965.EPI-10-0454.
   PubMed Web of Science ®Google Scholar
• Lorenzen, J. M., F. Martino, and T. Thum. 2012. “Epigenetic Modifications in Cardiovascular Diseases.” Basic Research in Cardiology 107 (2): 245. doi:10.1007/s00395-012-0245-9.
   PubMed Web of Science ®Google Scholar
• Liu, J., W. Lee, Z. Jiang, Z. Chen, S. Jhunjhunwala, P. M. Haverty, F. Gnad, et al. 2012. “Genome and Transcriptome Sequencing of Lung Cancers Reveal Diverse Mutational and Splicing Events.” Genome Research 22 (12): 2315–2327. doi:10.1101/gr.140988.112.
   PubMed Web of Science ®Google Scholar
• Lv, L., Y. Liu, P. Zhang, X. Zhang, J. Liu, T. Chen, P. Su, H. Li, and Y. Zhou. 2015. “The Nanoscale Geometry of TiO2 Nanotubes Influences the Osteogenic Differentiation of Human Adipose-Derived Stem Cells by Modulating H3K4 Trimethylation.” Biomaterials 39: 193–205. doi:10.1016/j.biomaterials.2014.11.002.
   PubMed Web of Science ®Google Scholar
• Ma, Z., D. Liu, S. Di, Z. Zhang, W. Li, J. Zhang, L. Xu, et al. 2019. “Histone Deacetylase 9 Downregulation Decreases Tumor Growth and Promotes Apoptosis in Non-Small Cell Lung Cancer after Melatonin Treatment.” Journal of Pineal Research 67 (2): e12587. doi:10.1111/jpi.12587.
   Web of Science ®Google Scholar
• Mazzone, R., C. Zwergel, M. Artico, S. Taurone, M. Ralli, A. Greco, and A. Mai. 2019. “The Emerging Role of Epigenetics in Human Autoimmune Disorders.” Clinical Epigenetics 11 (1): 34. doi:10.1186/s13148-019-0632-2.
   PubMedGoogle Scholar
• McDaniel, S. L., and B. D. Strahl. 2017. “Shaping the Cellular Landscape with Set2/SETD2 Methylation.” Cellular and Molecular Life Sciences : CMLS 74 (18): 3317–3334. doi:10.1007/s00018-017-2517-x.
   PubMed Web of Science ®Google Scholar
• Meerson, A., and H. Yehuda. 2016. “Leptin and Insulin Up-Regulate miR-4443 to Suppress NCOA1 and TRAF4, and Decrease the Invasiveness of Human Colon Cancer Cells.” BMC Cancer 16 (1): 882. doi:10.1186/s12885-016-2938-1.
   PubMedGoogle Scholar
• Meng, X., Y. Zhao, J. Liu, L. Wang, Z. Dong, T. Zhang, X. Gu, and Z. Zheng. 2019. “Comprehensive Analysis of Histone Modification-Associated Genes on Differential Gene Expression and Prognosis in Gastric Cancer.” Experimental and Therapeutic Medicine 18: 2219–2230. doi:10.3892/etm.2019.7808.
   PubMed Web of Science ®Google Scholar
• Miller, C. B., and M. Grunstein. 2006. “Genome-Wide Patterns of Histone Modifications in Yeast.” Nature Reviews. Molecular Cell Biology 7 (9): 657–666. doi:10.1038/nrm1986.
   PubMed Web of Science ®Google Scholar
• Monaghan, L., M. E. Massett, R. P. Bunschoten, S. Hoose, P.-A. Pirvan, R. M. J. Liskamp, H. G. Jorgensen, and X. Huaang. 2019. “The Emerging Role of H3K9me3 as a Potential Therapeutic Target in Acute Myeloid Leukemia.” Frontiers in Oncology 9: 1–16. doi:10.3389/fonc.2019.00705.
   PubMed Web of Science ®Google Scholar
• Mu, G., and F. Chen. 2020. “Oncogenic Roles of a Histone Methyltransferase SETDB2 In AML1-ETO Positive AML.” Cancer Management and Research 12: 783–792. doi:10.2147/CMAR.S227036.
   PubMed Web of Science ®Google Scholar
• Müller-Tidow, C., H.-U. Klein, A. Hascher, F. Isken, L. Tickenbrock, N. Thoennissen, S. Agrawal-Singh, Study Alliance Leukemia, et al. 2010. “Profiling of Histone H3 Lysine 9 Trimethylation Levels Predicts Transcription Factor Activity and Survival in Acute Myeloid Leukemia.” Blood 116 (18): 3564–3571. doi:10.1182/blood-2009-09-240978.
   PubMed Web of Science ®Google Scholar
• Nguyen, C. T., D. J. Weisenberger, M. Velicescu, F. A. Gonzales, J. C. Lin, and G. Liang. 2002. “Histone H3-Lysine 9 Methylation is Associated with Aberrant Gene Silencing in Cancer Cells and is Rapidly Reversed by 5-Aza-2’-Deoxycytidine.” Cancer Review 62: 6456–6461.
   PubMed Web of Science ®Google Scholar
• Nishida, N., and M. Kudo. 2013. “Oxidative Stress and Epigenetic Instability in Human Hepatocarcinogenesis.” Digestive Diseases 31 (5-6): 447–453. doi:10.1159/000355243.
   PubMed Web of Science ®Google Scholar
• Nishikawaji, T., Y. Akiyama, S. Shimada, K. Kojima, T. Kawano, Y. Eishi, Y. Yasuhito, and S. Tanaka. 2016. “Oncogenic Roles of the SETDB2 Histone Methyltransferase in Gastric Cancer.” Oncotarget 7 (41): 67251–67265. doi:10.18632/oncotarget.11625.
   PubMedGoogle Scholar
• Park, Y. S., M. Y. Jin, Y. J. Kim, J. H. Yook, B. S. Kim, and S. J. Jang. 2008. “The Global Histone Modification Pattern Correlates with Cancer Recurrence and Overall Survival in Gastric Adenocarcinoma.” Annals of Surgical Oncology 15 (7): 1968–1976. doi:10.1245/s10434-008-9927-9.
   PubMed Web of Science ®Google Scholar
• PEN 2014. The Project on Emerging Nanotechnologies. Washington, DC: The Woodrow Wilson International Center for Scholars.
   Google Scholar
• Pogribna, M., and G. Hammons. 2021. “Epigenetic Effects of Nanomaterials and Nanoparticles.” Journal of Nanobiotechnology 19 (1): 2. doi:10.1186/s12951-020-00740-0.
   PubMed Web of Science ®Google Scholar
• Pogribna, M., N. A. Koonce, A. Mathew, B. Word, A. K. Patri, B. Lyn-Cook, and G. Hammons. 2020. “Effect of Titanium Dioxide Nanoparticles on DNA Methylation in Multiple Human Cell Lines.” Nanotoxicology 14 (4): 534–553. doi:10.1080/17435390.2020.1723730.
   PubMed Web of Science ®Google Scholar
• Poziello, A., A. Nebbioso, H. G. Stunnenberg, J. H. A. Martens, V. Carafa, and L. Altucci. 2021. “Recent Insights into Histone Acetyltransferase-1: biological Function and Involvement in Pathogenesis.” Epigenetics 16 (8): 838–850. doi:10.1080/15592294.2020.1827723.
   PubMed Web of Science ®Google Scholar
• Qin, J., Z. Zeng, T. Luo, Q. Li, Y. Hao, and L. Chen. 2018. “Clinicopathological Significance of G9a Expression in Colorectal Carcinoma.” Oncology Letters 15 (6): 8611–8619. doi:10.3892/ol.2018.8446.
   PubMed Web of Science ®Google Scholar
• Ringrose, L., H. Ehret, and R. Paro. 2004. “Distinct Contributions of Histone H3 Lysine 9 and 27 Methylation to Locus-Specific Stability of Polycomb Complexes.” Molecular Cell 16 (4): 641–653. doi:10.1016/j.molcel.2004.10.015.
   PubMed Web of Science ®Google Scholar
• Rivenbark, A. G., W. B. Coleman, and B. D. Stahl. 2009. “Histone Methylation Patterns in Human Breast Cancer.” FASEB Journal 23 (1): S38.1.
   Google Scholar
• Roberti, A., A. F. Valdes, R. Torrecilla, M. F. Fraga, and A. F. Fernandez. 2019. “Epigenetics in Cancer Therapy and Nanomedicine.” Clinical Epigenetics 11 (1): 81. doi:10.1186/s13148-019-0675-4.
   PubMed Web of Science ®Google Scholar
• Schmittgen, T. D., and K. J. Livak. 2008. “Analyzing Real-Time PCR Data by the Comparative C(T) method.” Nature Protocols 3 (6): 1101–1108. doi:10.1038/nprot.2008.73.
   PubMed Web of Science ®Google Scholar
• Seidel, C., A. Kirsch, C. Fontana, A. Visvikis, A. Remy, L. Gaté, C. Darne, and Y. Guichard. 2017. “Epigenetic Changes in the Early Stage of Silica-Induced Cell Transformation.” Nanotoxicology 11 (7): 923–935. doi:10.1080/17435390.2017.1382599.
   PubMed Web of Science ®Google Scholar
• Seligson, D. B., S. Horvath, M. A. McBrian, V. Mah, H. Yu, S. Tze, Q. Wang, D. Chia, L. Goodglick, and S. K. Kurdistani. 2009. “Global Levels of Histone Modifications Predict Prognosis in Different Cancers.” The American Journal of Pathology 174 (5): 1619–1628. doi:10.2353/ajpath.2009.080874.
   PubMed Web of Science ®Google Scholar
• Setyawati, M. I., P. K. Khoo, B. H. Eng, S. Xiong, X. Zhao, and G. K. Das. 2013. “Cytotoxic and Genotoxic Characterization of Titanium Dioxide, Gadolinium Oxide, and Poly(Lactic-co-Glycolic Acid) Nanoparticles in Human Fibroblasts.” Journal of Biomedical Materials Research A 101: 633–640.
   PubMed Web of Science ®Google Scholar
• Shakeel, M., F. Jabeen, S. Shabbir, M. S. Asghar, M. S. Khan, and A. S. Chaudhry. 2016. “Toxicity of Nano-Titanium Dioxide (TiO2-NP) through Various Routes of Exposure: A Review.” Biological Trace Element Research 172 (1): 1–36. doi:10.1007/s12011-015-0550-x.
   PubMed Web of Science ®Google Scholar
• Sharma, S., K. C. Sarathlal, and R. Taliyan. 2019. “Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases.” CNS & Neurological Disorders Drug Targets 18 (1): 11–18. doi:10.2174/1871527317666181004155136.
   PubMed Web of Science ®Google Scholar
• Shi, H., V. Magaye, V. Casltranove, and J. Zhao. 2013. “Titanium Dioxide Nanoparticles: A Review of Current Toxicological Data.” Particle Fibre Toxicology 10 (15): 1–33.
   PubMed Web of Science ®Google Scholar
• Shi, Y., F. Lan, C. Matson, P. Mulligan, J. R. Whetstine, P. A. Cole, R. A. Casero, and Y. Shi. 2004. “Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1.” Cell 119 (7): 941–953. doi:10.1016/j.cell.2004.12.012.
   PubMed Web of Science ®Google Scholar
• Sierra, M. I., A. Valdes, A. F. Fernandez, R. Torrecillas, and M. F. Fraga. 2016. “The Effect of Exposure to Nanoparticles and Nanomaterials on the Mammalian Epigenome.” International Journal of Nanomedicine 11: 6297–6306. doi:10.2147/IJN.S120104.
   PubMed Web of Science ®Google Scholar
• Song, B., T. Zhou, W. Yang, J. Liu, and L. Shao. 2016. “Contribution of Oxidative Stress to TiO2 Nanoparticle-Induced Toxicity.” Environmental Toxicology and Pharmacology 48: 130–140. doi:10.1016/j.etap.2016.10.013.
   PubMed Web of Science ®Google Scholar
• Stoccoro, A., H. L. Karlsson, F. Coppede, and L. Migliore. 2013. “Epigenetic Effects of Nano-Sized Materials.” Toxicology 313 (1): 3–14. doi:10.1016/j.tox.2012.12.002.
   PubMed Web of Science ®Google Scholar
• Surapaneni, S. K., S. Bashir, and K. Tikoo. 2018. “Gold Nanoparticles-Induced Cytotoxicity in Triple Negative Breast Cancer Involves Different Epigenetic Alterations Depending Upon the Surface Charge.” Scientific Reports 8 (1): 12295. doi:10.1038/s41598-018-30541-3.
   PubMedGoogle Scholar
• Tamagawa, H., T. Oshima, M. Numata, N. Yamamoto, M. Shiozawa, S. Morinaga, Y. Nakamura, et al. 2013. “Global Histone Modification of H3K27 Correlates with the Outcomes in Patients with Metachronous Liver Metastasis of Colorectal Cancer.” European Journal of Surgical Oncology (EJSO) 39 (6): 655–661. doi:10.1016/j.ejso.2013.02.023.
   PubMed Web of Science ®Google Scholar
• Tarantini, A., R. Lanceleur, A. Mourot, M.-T. Lavault, G. Casterou, G. Jarry, K. Hogeveen, and V. Fessard. 2015. “Toxicity, Genotoxicity and Proinflammatory Effects of Amorphous Nanosilica in the Human Intestinal Caco-2 Cell Line.” Toxicology in Vitro 29 (2): 398–407. doi:10.1016/j.tiv.2014.10.023.
   PubMed Web of Science ®Google Scholar
• Taurozzi, J. S., and M. R. Wiesner. 2012a. Preparation of a Nanoscale TiO2 Aqueous Dispersion for Toxicological or Environmental Testing Version 1.2. NIST Special Publication 1200-3. Gaithersburg, MD: U.S. Dept. of Commerce, National Institute of Standards and Technology. doi:http://dx.doi.org/10.6028/NIST.SP.1200-3.
   Google Scholar
• Taurozzi, J. S., and M. R. Wiesner. 2012b. Preparation of Nanoscale TiO2 Dispersions in Biological Test Media for Toxicological Assessment Version 1.1. NIST Special Publication 1200-4. Gaithersburg, MD: U.S. Dept. of Commerce, National Institute of Standards and Technology doi:http://dx.doi.org/10.6028/NIST.SP.1200-4.
   Google Scholar
• Tzao, C., H.-J. Tung, J.-S. Jin, G.-H. Sun, H.-S. Hsu, B.-H. Chen, C.-P. Yu, and S.-C. Lee. 2009. “Prognostic Significance of Global Histone Modifications in Resected Squamous Cell Carcinoma of the Esophagus.” Modern Pathology 22 (2): 252–260. doi:10.1038/modpathol.2008.172.
   PubMed Web of Science ®Google Scholar
• Venza, M., M. Visalli, C. Beninati, G. V. De Gaetano, D. Teti, and I. Venza. 2015. “Cellular Mechanisms of Oxidative Stress and Action in Melanoma.” Oxidative Medicine and Cellular Longevity 2015: 481782. doi:10.1155/2015/481782.
   PubMed Web of Science ®Google Scholar
• Wang, J., B. G. Zhou, C. Chen, H. Yu, T. Wang, Y. Ma, G. Jia, et al. 2007. “Acute Toxicity and Biodistribution of Different Sized Titanium Dioxide Particles in Mice after Oral Administration.” Toxicology Letters 168 (2): 176–185. doi:10.1016/j.toxlet.2006.12.001.
   PubMed Web of Science ®Google Scholar
• Wang, J. X., Y. F. Li, G. Q. Zhou, B. Li, F. Jiao, C. Y. Chen, Y. X. Gao, Y. L. Zhao, and Z. F. Chai. 2007. “Influence of Intranasal Instilled Titanium Dioxide Nanoparticles on Monoaminergic Neurotransmitters of Female Mice at Different Exposure Time.” Zhonghau Yu Fang Yi Xue Za Zhi 41: 91–95.
   PubMedGoogle Scholar
• Wang, S., and Y. Wang. 2013. “Peptidylarginine Deiminases in Citrullination, Gene Regulation, Health and Pathogenesis.” Biochimica et Biophysica Acta 1829 (10): 1126–1135. doi:10.1016/j.bbagrm.2013.07.003.
   PubMed Web of Science ®Google Scholar
• Wong, B. S. E., Q. Hu, and G. H. Baeg. 2017. “Epigenetic Modulations in Nanoparticle-Mediated Toxicity.” Food and Chemical Toxicology 109 (Pt 1): 746–752. doi:10.1016/j.fct.2017.07.006.
   PubMedGoogle Scholar
• Xu, G., Z. Yang, Y. Ding, Y. Liu, L. Zhang, B. Wang, M. Tang, et al. 2021. “The Deubiquitinase USP16 Functions as an Oncogenic Factor in K-RAS-Driven Lung Tumorigenesis.” Oncogene 40 (36): 5482–5494. doi:10.1038/s41388-021-01964-6.
   PubMed Web of Science ®Google Scholar
• Xu, Q., X. Liu, S. Zhu, X. Hu, H. Niu, X. Zhang, D. Zhu, E. U. Nesa, K. Tian, and H. Yuan. 2018. “Hyper-Acetylation Contributes to the Sensitivity of Chemo-Resistant Prostate Cancer Cells to Histone Deacetylase Inhibitor Trichostatin A.” Journal of Cellular and Molecular Medicine 22 (3): 1909–1922. doi:10.1111/jcmm.13475.
   PubMed Web of Science ®Google Scholar
• Yang, P., L. Guo, Z. J. Duan, C. G. Tepper, L. Xue, X. Chen, H.-J. Kung, A. C. Gao, J. X. Zou, and H-W. Chen. 2012. “Histone Methyltransferase NSD2/MMSET Mediates Constitutive NF-κB Signaling for Cancer Cell Proliferation, Survival, and Tumor Growth via a Feed-Forward Loop.” Molecular and Cellular Biology 32 (15): 3121–3131. doi:10.1128/MCB.00204-12.
   PubMed Web of Science ®Google Scholar
• Yokoyama, Y., M. Hieda, Y. Nishioka, A. Matsumoto, S. Higashi, H. Kimura, H. Yamamoto, M. Mori, S. Matsuura, and N. Matsuura. 2013. “Cancer-Associated Upregulation of Histone H3 Lysine 9 Trimethylation Promotes Cell Motility In Vitro and Drives Tumor Formation In Vivo.” Cancer Science 104 (7): 889–895. doi:10.1111/cas.12166.
   PubMed Web of Science ®Google Scholar
• Zhang, T., E. Du, Y. Liu, J. Cheng, Z. Zhang, Y. Xu, S. Qi, and Y. Chen. 2020. “Anticancer Effects of Zinc Oxide Nanoparticles through Altering the Methylation Status of Histone on Bladder Cancer Cells.” International Journal of Nanomedicine 15: 1457–1468. doi:10.2147/IJN.S228839.
   PubMed Web of Science ®Google Scholar
• Zhang, X., W. Novera, Y. Zhang, and L.-W. Deng. 2017. “MLL5 (KMT2E): Structure, Function, and Clinical Relevance.” Cellular and Molecular Life Sciences : CMLS 74 (13): 2333–2344. doi:10.1007/s00018-017-2470-8.
   PubMed Web of Science ®Google Scholar
• Zhang, X., W. Li, and Z. Yang. 2015. “Toxicology of Nanosized Titanium Dioxide: An Update.” Archives of Toxicology 89 (12): 2207–2217. doi:10.1007/s00204-015-1594-6.
   PubMed Web of Science ®Google Scholar
• Zhao, X., F. Takabayashi, and Y. Ibuki. 2016. “Coexposure to Silver Nanoparticles and Ultraviolet a Synergistically Enhances the Phosphorylation of Histone H2AX.” Journal of Photochemistry and Photobiology. B, Biology 162: 213–222. doi:10.1016/j.jphotobiol.2016.06.046.
   PubMed Web of Science ®Google Scholar
• Zhen, L., L. Gui-lan, Y. Ping, H. Jin, and W. Ya-li. 2010. “The Expression of H3K9Ac, H3K14Ac, and H4K20TriMe in Epithelial Ovarian Tumors and the Clinical Significance.” International Journal of Gynecological Cancer 20 (1): 82–86.
   PubMed Web of Science ®Google Scholar